Gain Therapeutics, Inc. (GANX) vs Neonc Technologies Holdings, Inc. (NTHI)

A side-by-side comparison of Gain Therapeutics, Inc. and Neonc Technologies Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

GANX

Gain Therapeutics, Inc.

$72M

$1.69HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT

NTHI

Neonc Technologies Holdings, Inc.

$78M

$3.00HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT

Total return — GANX vs NTHI

growth of $100 · dividends reinvested · last 1y

GANX +2.4% (+2.4%/yr)NTHI -69.7% (-69.7%/yr)GANX compounded faster over this window

GANX NTHI

GANX vs NTHI: by the numbers

•NTHI is the larger company ($78M vs $72M market cap).
•Both run net losses; GANX's is the smaller (0.00% vs -155404.38% net margin).

Metrics side by side

Valuation

Metric	GANX	NTHI
P/B ratio	6.38	N/A

Profitability

Metric	GANX	NTHI
Gross margin	0.00%	100.00%
Operating margin	0.00%	-145459.36%
Net margin	0.00%	-155404.38%
ROE	-178.06%	N/A
ROIC	-159.24%	N/A

Growth (annualized)

Metric	GANX	NTHI
Total return CAGR (5Y)	-25.06%	N/A

Go deeper

Full GANX analysis Full NTHI analysis Interactive comparison tool

Dig into the metrics

Gain Therapeutics ROE Neonc Technologies ROE Gain Therapeutics operating margin Neonc Technologies operating margin Gain Therapeutics revenue growth Neonc Technologies revenue growth Gain Therapeutics free cash flow Neonc Technologies free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.